Literature DB >> 21569788

Nickel differentially regulates NFAT and NF-κB activation in T cell signaling.

Rumiko Saito1, Satoshi Hirakawa, Hiroshi Ohara, Makoto Yasuda, Tomomi Yamazaki, Shigeaki Nishii, Setsuya Aiba.   

Abstract

Nickel is a potent hapten that induces contact hypersensitivity in human skin. While nickel induces the maturation of dendritic cells via NF-κB and p38 MAPK activation, it also exerts immunosuppressive effects on T cells through an unknown mechanism. To elucidate the molecular mechanisms of its effects on T cells, we examined the effects of NiCl(2) on mRNA expression in human CD3+ T cells stimulated with CD3 and CD28 antibodies. Using a DNA microarray and Gene Ontology, we identified 70 up-regulated (including IL-1β, IL-6 and IL-8) and 61 down-regulated (including IL-2, IL-4, IL-10 and IFN-γ) immune responsive genes in NiCl(2)-treated T cells. The DNA microarray results were verified using real-time PCR and a Bio-Plex(TM) suspension protein array. Suppression of IL-2 and IFN-γ gene transcription by NiCl(2) was also confirmed using Jurkat T cells transfected with IL-2 or IFN-γ luciferase reporter genes. To explore the NiCl(2)-regulated signaling pathway, we examined the binding activity of nuclear proteins to NFAT, AP-1, and NF-κB consensus sequences. NiCl(2) significantly and dose-dependently suppressed NFAT- and AP-1-binding activity, but augmented NF-κB-binding activity. Moreover, NiCl(2) decreased nuclear NFAT expression in stimulated T cells. Using Jurkat T cells stimulated with PMA/ionomycin, we demonstrated that NiCl(2) significantly suppressed stimulation-evoked cytosolic Ca(2+) increases, suggesting that NiCl(2) regulates NFAT signals by acting as a blocker of Ca(2+) release-activated Ca(2+) (CRAC) channels. These data showed that NiCl(2) decreases NFAT and increases NF-κB signaling in T cells. These results shed light on the effects of nickel on the molecular regulation of T cell signaling.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569788     DOI: 10.1016/j.taap.2011.04.017

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Oxidative stress and inflammatory responses involved in dietary nickel chloride (NiCl2)-induced pulmonary toxicity in broiler chickens.

Authors:  Jie Deng; Hongrui Guo; Hengmin Cui; Jing Fang; Zhicai Zuo; Junliang Deng; Xun Wang; Ling Zhao
Journal:  Toxicol Res (Camb)       Date:  2016-07-08       Impact factor: 3.524

2.  Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivity.

Authors:  Yutaka Kimura; Hitoshi Terui; Chizu Fujimura; Ryo Amagai; Toshiya Takahashi; Setsuya Aiba
Journal:  Arch Toxicol       Date:  2021-06-27       Impact factor: 5.153

3.  Nickel chloride (NiCl2)-caused inflammatory responses via activation of NF-κB pathway and reduction of anti-inflammatory mediator expression in the kidney.

Authors:  Hongrui Guo; Huidan Deng; Hengmin Cui; Xi Peng; Jing Fang; Zhicai Zuo; Junliang Deng; Xun Wang; Bangyuan Wu; Kejie Chen
Journal:  Oncotarget       Date:  2015-10-06

4.  Migratory dendritic cells in skin-draining lymph nodes have nickel-binding capabilities.

Authors:  Toshinobu Kuroishi; Kanan Bando; Reiska Kumala Bakti; Gaku Ouchi; Yukinori Tanaka; Shunji Sugawara
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

5.  An international validation study of the IL-2 Luc assay for evaluating the potential immunotoxic effects of chemicals on T cells and a proposal for reference data for immunotoxic chemicals.

Authors:  Yutaka Kimura; Rie Yasuno; Mika Watanabe; Miwako Kobayashi; Tomoko Iwaki; Chizu Fujimura; Yoshihiro Ohmiya; Kohji Yamakage; Yoshihiro Nakajima; Mayumi Kobayashi; Nana Mashimo; Yumi Takagi; Takashi Omori; Emanuela Corsini; Dori Germolec; Tomoaki Inoue; Erwin L Rogen; Hajime Kojima; Setsuya Aiba
Journal:  Toxicol In Vitro       Date:  2020-03-18       Impact factor: 3.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.